Diseases & Conditions >
This topic is from The 5-Minute Clinical Consult About our sources

Hypereosinophilic Syndrome Updated 4/2011

Email       Print Section  |  Print Topic       Add to My Favorites

BASICS

  • Description
  • Epidemiology
  • Risk Factors
  • General Prevention
  • Pathophysiology
  • Etiology

DIAGNOSIS

  • Signs and Symptoms
  • Tests
  • Differential Diagnosis

TREATMENT

  • Medication (Drugs)
  • Additional Treatment
  • Surgery
  • In-patient Considerations

Ongoing Care

  • Follow-Up Recommendations
  • Prognosis
The following is an excerpt....
BASICS
Description

Hypereosinophilic syndrome (HES): A heterogeneous group of chronically high eosinophil states characterized by

  • A persistently elevated eosinophil count >1,500 cells/μL for at least 6 months
  • Eosinophil-induced end-organ damage
  • Exclusion of other causes (e.g., parasitic infection, allergy, malignancy, collagen-vascular disease)
  • There are several patient subsets within HES.
    • FIP1L1/PDGFRα-associated (F/P+) HES: Myeloproliferative HES, chronic eosinophilic leukemia (CEL)
    • F/P– HES:
      • Lymphocytic HES (L-HES): CD3-/CD4+ T-lymphocytes produce IL-5
      • Organ-restricted disease, e.g., eosinophilic esophagitis
    • Idiopathic HES
  • System(s) affected: Hematologic; Cardiac; Cutaneous; Pulmonary; Nerologic; GI; Rheumatologic; Ocular
  • Synonym(s): Disseminated eosinophilic collagen disease; Löeffler’s fibroplastic endocarditis with eosinophilia (not currently used)

Epidemiology

A rare condition, typically ...

You must be logged in to fully access this content.

Sign In
Sign up for a 30-Day Free Trial

Sign up for a 30-Day FREE Trial now and receive access to all content.

Start free trial!

Have a book code?

Submit your book code to create your FREE standard account.